Skip to main content
Equibles
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc.

Track LCTX — free

Use LCTX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.08 -0.02 (-1.82%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Customer concentration — top 2 customers 92% of revenue

2 customers — 92% of revenue (the year ended December 31, 2025)

“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”

One customer — 92% of revenue (the year ended December 31, 2024)

“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
View the 10-K filed Mar 5, 2026
Market Cap
$273.14M
Shares
252.91M

Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.

Query congressional trades through the STOCK Act API or MCP →

No Congressional Trades

No congressional trading data is available for this listed security yet.

Key facts CIK 876343 CUSIP 53566P109 13F (30d) 79 filings 79 filers Visit website Investor relations